NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 230 filers reported holding NEKTAR THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $170,000 | -62.5% | 30,507 | -8.9% | 0.00% | 0.0% |
Q4 2021 | $453,000 | -93.3% | 33,500 | -47.2% | 0.00% | -75.0% |
Q1 2018 | $6,742,000 | +3986.1% | 63,422 | +330.3% | 0.00% | +300.0% |
Q3 2015 | $165,000 | -30.7% | 14,739 | -22.4% | 0.00% | 0.0% |
Q2 2015 | $238,000 | +73.7% | 19,002 | +66.8% | 0.00% | – |
Q3 2014 | $137,000 | +9.6% | 11,390 | +3.1% | 0.00% | -100.0% |
Q4 2013 | $125,000 | -47.5% | 11,043 | -50.4% | 0.00% | 0.0% |
Q3 2013 | $238,000 | +28.6% | 22,262 | +38.5% | 0.00% | -50.0% |
Q2 2013 | $185,000 | -68.3% | 16,074 | -69.7% | 0.00% | -66.7% |
Q1 2013 | $583,000 | +30.7% | 53,051 | -11.8% | 0.01% | +20.0% |
Q4 2012 | $446,000 | – | 60,168 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |